New Genotype-guided Treatment in Newly Diagnosed PTCL

NCT07706959 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

NOT_YET_RECRUITING

Status

108

Enrollment

OTHER

Sponsor class

Conditions

Peripheral T-cell Lymphoma (PTCL)

Interventions

DRUG: Azacitidine plus Selinexor with CHOP
DRUG: Decitabine plus Selinexor with CHOP
DRUG: Zeprumetostat plus chidamide with CHOP
DRUG: Azacitidine plus Golidocitinib with CHOP
DRUG: CHOP

Sponsor

Ruijin Hospital